Dipeptidyl peptidase-4 inhibitors and preservation of pancreatic islet-cell function: a critical appraisal of the evidence.
about
An Update on the Effect of Incretin-Based Therapies on β-Cell Function and MassAssessment of pancreatic β-cell function: review of methods and clinical applicationsUnraveling oxyntomodulin, GLP1's enigmatic brotherEfficacy and safety of adding evogliptin versus sitagliptin for metformin-treated patients with type 2 diabetes: A 24-week randomized, controlled trial with open label extensionA phospho-BAD BH3 helix activates glucokinase by a mechanism distinct from that of allosteric activatorsEmerging gliptins for type 2 diabetes.Combination of linagliptin and metformin for the treatment of patients with type 2 diabetes.Design and baseline characteristics of the CARdiovascular Outcome Trial of LINAgliptin Versus Glimepiride in Type 2 Diabetes (CAROLINA®)Comparative analysis of therapeutic efficiency and costs (experience in Bulgaria) of oral antidiabetic therapies based on glitazones and gliptins.Reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: role of dipeptidyl peptidase-IV inhibition.Effects of dipeptidyl peptidase-4 inhibitors on beta-cell function and insulin resistance in type 2 diabetes: meta-analysis of randomized controlled trials.Comparative clinical pharmacokinetics of dipeptidyl peptidase-4 inhibitors.Linagliptin/Metformin fixed-dose combination treatment: a dual attack to type 2 diabetes pathophysiology.Extra-pancreatic effects of incretin-based therapies: potential benefit for cardiovascular-risk management in type 2 diabetes.Cardiovascular effects of gliptins.Pharmacological treatment of diabetes in older people.A review of gliptins for 2014.DPP-4 inhibitors in diabetic complications: role of DPP-4 beyond glucose control.In vivo dual-delivery of glucagon like peptide-1 (GLP-1) and dipeptidyl peptidase-4 (DPP4) inhibitor through composites prepared by microfluidics for diabetes therapy.Renoprotective Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin: A Review in Type 2 Diabetes.A review of reviews: a virtual issue.Dipeptidyl peptidase-4 inhibitor sitagliptin improves pancreatic β-cell function in hypertensive diabetic patients treated with angiotensin receptor blockers.Clinical and Physiological Characterization of Elevated Plasma Glucagon-Like Peptide-1 Levels (Hyperglipemia) in a Dipeptidyl Peptidase IV Mutation Carrier.Add on DPP-4 inhibitor alogliptin alone or in combination with pioglitazone improved β-cell function and insulin sensitivity in metformin treated PCOS.Effect of Linagliptin and Voglibose on metabolic profile in patients with Type 2 Diabetes: a randomized, double-blind, placebo-controlled trial.
P2860
Q26749089-0AF6A08A-8039-4AE2-B274-46A5166D9336Q26829445-CC8A0C84-C700-4420-B934-35572AA535B3Q27001704-95F473CB-E159-4237-AB5F-B6AC2D79D75EQ33626226-CB6540EA-4225-4752-8BDF-8563B90147B8Q33855651-4D310687-2D7A-4736-B206-2CE54DE71049Q34347884-ECA2913F-3471-46ED-AE5E-8E30D3518E8FQ34824247-02D128F1-9A13-4F4B-B2C7-25E7C3EE3079Q35330816-C5DA55E7-46C5-4D34-9A7C-B3CCEC2047D6Q35964678-2E0E5B61-9B5B-4DBF-9641-4225773D6DE3Q36249602-61DE8D0E-526C-4D3A-B67E-A3E2D1902B32Q36315963-37255D7C-1196-4100-ABE7-1089407570B9Q38017726-ECCA7E2B-35B4-4860-B2CC-7D6163651B0BQ38062881-6D7D4052-851B-4281-A59C-40DDC9D089AEQ38065321-CBBC9D18-3FD6-449D-974A-2EBDD356575DQ38072259-6970C27F-C3B5-43B3-ADEA-27E7359E60B7Q38235153-39A497A8-6DA3-4FAD-BEF7-F785DFF7E511Q38266290-7CB1E9F1-916A-4FB3-8074-85DFE5895801Q38922177-E9C4979C-A91E-4960-B65B-3CD0AD521B13Q39790895-DEB44997-CACB-4BA2-B6B0-D0B168548F20Q42876331-1944B396-1EAC-45AF-979E-6C2B84391207Q45891354-A125CB2B-809F-42DD-9881-93138063D2BAQ51299686-E66D9244-DFD6-4605-85F1-CAC0C97E54C2Q52647767-78A8AC68-F6F4-45FE-86B0-3B7F22272C00Q53746829-45470CF8-B1D0-4859-BA75-11F45F717E25Q55518630-74F4BCA2-DB33-4155-86F6-98ACC8584CB6
P2860
Dipeptidyl peptidase-4 inhibitors and preservation of pancreatic islet-cell function: a critical appraisal of the evidence.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Dipeptidyl peptidase-4 inhibit ...... cal appraisal of the evidence.
@en
Dipeptidyl peptidase-4 inhibit ...... cal appraisal of the evidence.
@nl
type
label
Dipeptidyl peptidase-4 inhibit ...... cal appraisal of the evidence.
@en
Dipeptidyl peptidase-4 inhibit ...... cal appraisal of the evidence.
@nl
prefLabel
Dipeptidyl peptidase-4 inhibit ...... cal appraisal of the evidence.
@en
Dipeptidyl peptidase-4 inhibit ...... cal appraisal of the evidence.
@nl
P2093
P2860
P1476
Dipeptidyl peptidase-4 inhibit ...... cal appraisal of the evidence.
@en
P2093
D H van Raalte
R E van Genugten
P2860
P304
P356
10.1111/J.1463-1326.2011.01473.X
P577
2011-11-21T00:00:00Z